The opioid addiction market is set to grow from $2billion in 2023 to $2.4billion by 2033 in regions including the US, UK, France, Germany, Italy, Spain, Canada, and Australia, according to GlobalData. New drugs include cannabidiol, mazindol controlled release, probenecid and TRV-734.


